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Lenburg organizes his book starting with a 
“nutshell” history of animated cartoons and 
then proceeds with major sections on silent 
cartoon series, theatrical sound cartoons, full-
length animated features, animated television 
specials, and TV cartoon series.  Each entry 
provides historical background information, 
voice credits (except for the silent productions), 
the year produced, and complete filmographies 
when appropriate.  Lenburg follows these 
sections on the specific cartoons and cartoon 
series with ones on awards and honors and a 
chronology entitled milestones of animation. 
He ends the book with a selected bibliography 
and a general index.  There are black and white 
images throughout the volume but the section 
of color plates in the middle is interesting and 
fun to browse with images ranging from the 
Chipmunks to Bevis and Butthead, Doones-
bury to Davey and Goliath, and Felix the Cat 
to Shrek.  The Encyclopedia	 of	Animated	
Cartoons is another one of those reference 
works that appeals to readers because it is 
not only useful in finding elusive facts, it also 
offers the enjoyment of browsing that sparks 
new discoveries. 
Libraries that have found the various Grey 
House Publishing directories and statistical 
handbooks valuable will be glad that a num-
ber of new 2008 and 2009 editions are now 
available.
One of the more popular, America’s	Top	
Rated	Cities:	a	Statistical	Handbook (2008, 
9781592373499, $225) is now in its fifteenth 
edition.  Divided into four volumes by region; 
Southern, Western, Central and Eastern, this 
set continues to provide background, rankings 
and numerous statistical tables drawn from 
a variety of sources on the top 100 cities in 
America.  Sixteen new cities have made the 
most recent list and of course 16 have been 
removed.  Statistics and ratings related to 
education, employment, income, government 
expenditures, real estate, transportation, and 
business are all included.  Smartly compiled 
with an assortment of useful information, 
libraries that have purchased earlier editions 
will want to continue that tradition.
A new edition of the companion set to this 
work.  America’s	Top	Rated	Smaller	Cities:	
a	 Statistical	Handbook	 2008/2009 (978-1-
59237-284-3, $195) is also available from 
Grey House.  This is the seventh edition of 
this work and it consists of two volumes ar-
ranged alphabetically by state and covering 111 
smaller cities ranging from Dublin, OH to Rio 
Rancho, NM and from Folsom, CA to Frank-
lin, TN.  The contents are similar to the larger 
four-volume set with background, ratings and 
numerous statistical tables being provided for 
each city.  Both these sources provide useful 
and fascinating information for those research-
ing their home town or contemplating a move 
to a new locale.
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from Grey House is the fifteenth edition 
of the Complete	 Learning	 Disabilities	
Directory (2008, 978-1592373680, $145). 
This resource affords a comprehensive and 
compact guide to a wealth of helpful infor-
mation, not only for those who are learning 
disabled, but also to their families and the 
professionals that serve them.  The nearly 
5,000 entries in this work offer detailed 
information about associations and govern-
ment agencies, camps and summer programs, 
conferences and workshops, resources for 
literacy and learning skills, exchange pro-
grams, professional periodicals and texts, 
testing resources, and schools and colleges. 
It also contains sections that offer guidance 
on computer resources as well as other media 
ranging from books to pamphlets to videos 
and Websites.  Each entry provides the es-
sential information to access, contact or 
purchase the resources covered.  As a value 
added resource the National Center for 
Learning Disabilities’ advocacy brief Un-
derstanding the Standards-based Individual-
ized Education Programs is provided.  This 
brief explains the Standards based IEP which 
is being adopted by school districts across 
the country.  Academic libraries supporting 
special education programs as well as public 
libraries where there is interest will find this 
a valuable guide for students, professionals 
and the general reader.  
continued on page 59
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Column	Editor’s	Note:  In this issue, I am pleased to offer insights from two new review-
ers: Katherine	Head and Amber	Malcolm.  Both of ATG’s newest reviewers are graduate 
students at the School of Library and Information Science at the University	of	South	Carolina. 
They present thoughtful reviews on books that are sure to peak your patrons’ (and perhaps 
even your own!) interest.  Katherine examines Melody	Peterson’s Our	Daily	Meds.  She has 
learned about the pharmaceutical and medical industries through her own searching and 
with the guidance of a husband in a health profession, though she freely acknowledges her 
generalist status.  Amber, a Disney enthusiast, hopes to one day work in the Big Apple at the 
Museum	of	Natural	History or the New	York	Public	Library.  A hearty welcome to these 
budding information specialists, and happy reading, everyone! — DV
Gabler, Neal.  Walt	Disney:	The	Triumph	of	the	American	Imagination.  New York: 
Knoph, 2006.  9780679438229.  880 pages.  $40.00. 
 
Reviewed by Amber Malcolm  (Graduate Student, School of Library and  
Information Science, University of South Carolina)
Neal Gabler’s biography of Walt	Disney:	
The	Triumph	of	 the	American	Imagination 
provides an intensive look into one of the 
world’s most well known names.  Beginning 
with a comprehensive look at Walt Disney’s 
family roots, Gabler takes the reader through 
Disney’s life in an attempt to explain the mo-
tivations and reasoning behind the man who 
became an American legend.  Gabler divides 
the biography into eleven chapters — each 
chapter discussing a specific period in Disney’s 
life.  To set the tone and pace of each chapter, 
Gabler uses descriptive words and phrases for 
the titles.  He then stays true to the titles in such 
a way that the reader is drawn completely into 
an unknown side and world of Walt Disney. 
Starting with the first chapter, “Escape,” Ga-
bler pinpoints the fact that Walt was always 
looking for an “Escape” and that this was his 
main motivation throughout his life.  Gabler 
details the Disney family legacy, which allows 
the reader to see a family that was constantly 
searching for something better, a way to “Es-
cape” the realities of the world.  “Escape” 
dives head first into chapter two, “Go-Get-
ter,” in which Gabler plunges the reader into 
Walt’s mindset as he realizes his destiny lies 
with animation.  Gabler captures the sense of 
urgency and motivation with which Disney 
threw himself into being the best animator 
possible while maintaining his underlying goal 
of creating a way to “Escape” from reality. 
When Walt does not get the results he hoped 
from the small city, he uproots to Hollywood, 
which becomes a “Wonderland,” the title of 
the third chapter, for all of his dreams.  What 
starts out as an “Escape” and “Wonderland” 
soon leads to a sour turn of events — Walt’s 
company, The Disney Brothers, lost several 
of their animators in a production company 
dispute and are forced to start over. 
Gabler transitions into “The Mouse,” the 
fourth chapter, named due to Walt’s most 
famous character, created not from ingenuity, 
but out of necessity.  Mickey Mouse starred 
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in a few cartoons, namely Steamboat Willie, one 
of the first sound cartoons, and was an instant hit. 
The fifth chapter discusses “The Cult” that arose 
from Mickey’s success and how it forever changed 
animation and Walt’s life.  In “Folly,” Walt once 
more is blazing the trail in an effort to create an 
“Escape” and on-screen “Wonderland” by mak-
ing the first full length animated feature.  Snow 
White and the Seven Dwarfs was an incredible 
success, and from there, it appeared Walt could 
do no wrong — he was at the top of the mountain, 
or “Parnassus,” as the seventh chapter is called. 
Walt’s company produced a few films before re-
ality caught up as World War II broke out. “Two 
Wars” discusses not only the Disney company’s 
involvement in the war effort and the reasoning 
behind it, but also the infamous workers strike at 
the company.  Even with reality taking over his 
studio, Walt still attempted to “Escape” by going 
to South America to get inspiration for more films. 
The outcome of the actual “Two Wars” left the 
Disney studios somewhat “Adrift,” as the ninth 
chapter focuses on Walt’s attempt to return to his 
original goal of creating his own reality 
and “Escape,” though he does not find 
his focus until chapter ten.  “City on a 
Hill” shows the “Go-Getter” side of 
Disney melding with his want for an 
“Escape” in his attempt to create a 
new kind of amusement park.  Dis-
ney was able to realize his dream 
for a created reality of which he was 
in control, and despite his age and 
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decreasing health, Disney rallied his “Go-Get-
ter” attitude to continue improving the world 
around him.  The final chapter, “Slouching to 
Utopia,” presents Walt in his final days as he 
tried to quickly accomplish as many plans as 
possible in his realization of his failing health. 
The biography ends with the death of Walt, 
who changed America in so many ways, but 
also shows that his legacy is an ongoing process 
— always changing and always improving, just 
as Disney lived his life. 
This biography is intended for avid Disney 
fans who want to know more about what drove 
the man who became a household name world-
wide.  Gabler maintains an unbiased tone, 
presenting several accounts of the stories he 
includes, though one can see that Gabler holds 
Disney in high regard.  Gabler does not appear 
to have any previous affinity or bias towards 
Disney.  He has authored three other books, 
all dealing with Hollywood and celebrities. 
Gabler has been published in several leading 
newspapers and magazines, such as The New 
York Times and Vogue.  He also has experience 
in television and currently works for PBS. 
Gabler truly did his research, much of it coin-
ciding with the reviewer’s previous knowledge 
on Walt Disney.  The information had 
an in-depth quality about it, and over-
all the biography was 
very thorough 
and offered a 
new perspective 
for the reviewer. 
The name “Walt 
Disney” and all 
that goes along 
with it is a daily part of a large majority of the 
world today.  While this book appears to be written 
for individuals who share a passion for knowing 
more about the man, Walt Disney, it could defi-
nitely be an interesting read to those with only a 
mild interest.  The Disney company has permeated 
almost every aspect of people’s lives, and so it is 
a book just about any person off the street could 
relate to. 
The reviewer firmly believes that this book 
definitely appeals to a certain audience.  The im-
portance of the subject matter, Walt Disney’s life, 
is up to the individual who might read the book. 
The reviewer has a rather extensive knowledge of 
Walt Disney and his empire from several other 
books, but was excited to read another book with 
a different perspective on the subject.  This book 
was one of the best on Disney and his life and 
legacy and the reviewer feels it truly encompassed 
the real Walt Disney and what motivated him. 
The strengths of this book are too numerous to 
elaborate on each, but there are one or two that 
are worthy of mention.  Gabler’s chapter titles 
not only set the tone and pace of the chapters, 
but also reflected Walt’s life in its entirety.  One 
could almost graph Walt’s life based on the 
chapter titles and pinpoint his accomplishments 
and defeats as well.  Gabler also took the chapter 
titles one step further and really made each chapter 
its own.  The “Go-Getter” and “Parnassus” are 
the best examples; while reading “Go-Getter,” 
the reader gets so caught up in whether or not 
Disney will be able to succeed, despite knowing 
the end result.  Gabler’s writing style draws the 
reader into Walt’s life, and the reader is able to 
really experience the ups and downs alongside 
continued on page 60
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Walt and his company.  The book does not 
just take on a lackadaisical view of Disney’s 
life; instead it becomes the reader’s created 
reality, with Gabler following in Walt’s 
footsteps — creating a reality and an escape 
for the people around him.  The only weak-
Petersen, Melody.  Our	Daily	Meds:	How	the	Pharmaceutical	Companies		
Transformed	Themselves	Into	Slick	Marketing	Machines	and	Hooked		
the	Nation	on	Prescription	Drugs. New York: Sarah Crichton  
Books, 2008.  432 pages.  9780374228279.  $26.00. 
 
Reviewed by Katherine E. B. Head  (Graduate Student, School of Library  
and Information Science, University of South Carolina)
macia (now owned by Pfizer) to market their 
incontinence medication, Detrol, to a larger 
audience.  They “sold” the phrase by paying 
physicians and celebrities such as Mary Lou 
Retton to speak of the serious detriment that 
an overactive bladder has on a person’s life. 
With a new law permitting television adver-
tisements for prescription medications, the 
company reached their target audience easily. 
The same marketing strategy was applied for 
PMDD (premenstrual dysphoric disorder). 
“Think it’s PMS?  It could be PMDD,” said 
Eli Lilly’s commercials for Sarafem, a pink 
and lavender repackaging of Prozac. 
The industry is increasingly marketing 
toward a younger audience to gain life-time 
customers.  National Depression Screening 
Day is a campaign organized by Screening 
for Mental Health, Inc. (funded by Eli Lilly, 
Pfizer, Wyeth, Forest Laboratories, and 
GlaxoSmithKline — all makers of anti-de-
pressant drugs).  The day involves “screening” 
college students with brief surveys looking 
for symptoms of stress, anxiety, and sadness 
— all symptoms one would expect in the 
average college student.  At Central College 
in Pella, Iowa, the results of the screening 
indicated “almost half” of the 190 students 
who took the test scored “diagnosis likely, 
further evaluation needed.” 
The information in Petersen’s nonfiction 
book is relevant to every American, as we 
are exposed to pharmaceutical marketing 
when we watch television or read a magazine. 
The free samples we get from our doctors 
would not be there without pharmaceutical 
companies’ marketing strategies.  We should 
all be informed consumers.  While Petersen 
does not downplay the real need for phar-
maceutical medications, she challenges the 
deceptive mass marketing strategies that 
have become commonplace in the industry. 
The book is well worth the price.  It might 
save you hundreds of dollars on unnecessary 
prescriptions, and an informed consumer can 
ask doctors better questions and recognize 
marketing schemes. 
Melody Petersen is a journalist who 
covered pharmaceutical companies for the 
New York Times from 1999 until 2003.  On 
the same subject is Hooked: Ethics, Medicine, 
and Pharma by Howard Brody, MD, PhD. 
On his blog, Brody credits Petersen with her 
series of articles in the Times for inspiring his 
work.  Petersen’s book is straightforward and 
understandable for someone without a back-
ground in the medical field.  It is loaded in the 
back with a Notes section, full of citations and 
support for her claims.  This reviewer only 
has two complaints: 1) Topics are sometimes 
dropped and revisited later, making the book 
occasionally seem out of chronological and/or 
sequential order.  Nevertheless, it was not a 
difficult book to follow overall; and 2) In the 
first chapter, Petersen briefly diverts from 
pharmaceutical companies and prescrip-
tion drugs to share statistics about money 
wasted on unnecessary tests and procedures. 
The paragraph is not long enough for her to 




ness of the book, according to the reviewer, 
is the size of the book.  First impressions 
make the book appear to be an extremely 
daunting task, with over 800 pages to read. 
On second glance, one realizes that 200 of 
the final pages are appendices.  Overall, the 
reviewer thoroughly enjoyed this biography 
and recommends it for any Walt Disney fan, 
new or old.
Over the last two decades, large companies 
such as Merck, Bristol-Meyers Squibb, Phiz-
er, and more have increasingly hired business 
executives and marketers to run their compa-
nies.  The effect has been increased sales, but 
sometimes at the peril of the patient. 
Americans are taking enough medications 
to supply plenty of excess income to major 
pharmaceutical producers, which largely 
goes toward more marketing.  According to 
a study by the Kaiser Family Foundation 
in May 2007, the average American picked 
up more than twelve different prescriptions 
from the pharmacy in 2006, up from eight in 
2004.  Pharmaceutical companies court physi-
cians with extravagant vacations, dinners, and 
lunches while promoting the latest prescription 
drug.  In 2002, Forest Labs paid for hundreds 
of events including a lavish French dinner at 
Daniel in Manhattan to promote their new drug 
Lexapro, at which they paid physicians $500 
to attend.  Such dinners and conferences some-
times pose as continuing education, although 
they are marketing ploys to convince doctors 
to write more prescriptions for the given drug. 
Pharmaceutical companies pay physicians to 
promote the drug to other physicians without 
disclosing their financial ties. 
A danger in these promotions is that they are 
sometimes based on weak or faulty evidence 
of the drug’s efficacy.  Until recent legislation 
requiring that pharmaceutical companies re-
lease all studies for new drugs, some companies 
hid results, and only released results that were 
favorable.  Merck, the makers of Vioxx, could 
have prevented thousands of deaths if they 
had not suppressed their original findings that 
Vioxx increases risk of heart attacks more than 
other pain medications.  It took several years 
of being on the market before it was pulled in 
2004, but in November of that year, a scientist 
from the FDA testified that Vioxx may have 
caused heart attacks in as many as 139,000 
Americans.  Pharmaceutical companies have 
also performed unethical research.  Novartin’s 
trial for Ritalin LA removed participants with 
negative effects from the pre-trial.  The indus-
try has been known to hire ghostwriters to pro-
duce articles that depict their drug favorably, 
regardless of whether the research is valid. 
The company pays physicians to “author” 
such articles by “editing,” then attaching their 
name and submitting it to a medical journal or 
other source for publication.  According to the 
documents of an ex-insider of a major pharma-
ceutical company, the marketing firm Medical 
Education Systems performed such ghostwrit-
ing services for Parke-Davis’ drug, Neurontin. 
The faxed status report read “DRAFT COM-
PLETED.  WE JUST NEED AN AUTHOR.” 
This highlights the importance of peer-review 
for journals.  Unfortunately, even reviewers 
occasionally have had ties to the industry.  
In congruence with Petersen’s claims 
that physicians accept financial ties to the 
pharmaceutical industry, medical associations 
are beginning to acknowledge the problem by 
advocating against it.  The National Physi-
cians Alliance has launched the “Unbranded 
Doctor Campaign” to encourage all medical 
professionals to eliminate the acceptance of 
gifts from pharmaceutical companies and 
reduce the influence those companies have on 
the field.  NoFreeLunch.org is a not-for-profit 
group of health care providers who “believe 
that pharmaceutical promotion should not 
guide practice.” 
Mass amounts of money are spent on mar-
keting while research time is spent on creating 
copy-cat drugs.  Zantac, for example, is a copy-
cat of Tagamet.  Vioxx was a copy-cat of Ce-
lebrex.  Rather than devote R&D time toward 
moving forward, pharmaceutical companies 
look for ways to create the next “blockbuster” 
drug.  With massive marketing campaigns and 
a drug that works just differently enough to 
claim some type of “one-up” on its original, 
the industry makes billions off copy-cat drugs. 
“In 1986 Zantac passed Tagamet to become the 
biggest-selling drug on earth” by marketing 
essentially the same product toward heartburn 
sufferers to increase the consumer numbers, 
rather than focus on Tagamet’s original purpose 
as a healer for stomach ulcers. 
Rather than search for cures, companies 
focus on chronic ailments to ensure lifelong 
customers.  The industry also uses marketing 
to create the perception of chronic ailments 
previously unlabeled as such.  For example, 
“overactive bladder” was coined by Phar-
